| Study characteristics |
| Patient Sampling |
Retrospective case‐control study; 128 topographic images of 128 people were selected at the Singapore National Eye Center |
| Patient characteristics and setting |
The forme fruste keratoconus group (24 images) involved clinically and topographically normal eyes with the contralateral eye showing frank keratoconus. These cases were obtained from the database of people with keratoconus from the Singapore National Eye Center. The diagnosis of keratoconus in the contralateral eye was reconfirmed by clinical examination and evaluation of topographies from the Orbscan IIz corneal topography system (Bausch + Lomb TechnoLas, Munich, Germany) and Tomey keratoconus screening system (TMS, software version 2.4.2J, Tomey TMS‐2N; Tomey Corp, Nagoya, Japan) by a corneal sub‐specialist.
The control group (104 images) involved normal preoperative topographies of people who had myopic LASIK (with or without astigmatism) performed at least 4 years before with no resultant ectasia.
|
| Index tests |
The SCORE Analyzer is based on a linear regression analysis that constructs a set of linear functions of variables known as discriminant functions. It combines 12 Placido and tomographic indices in a weighted fashion to classify corneas as suspicious for keratoconus or normal. |
| Target condition and reference standard(s) |
Clinically evident keratoconus was defined by evidence of ≥ 1 slit‐lamp biomicroscopic findings including conical protrusion of the cornea at the apex, Fleischer's ring, Vogt's striae, and corneal stromal thinning. The classification was performed by 1 corneal specialist. Cases were classified before inclusion. |
| Flow and timing |
All cases were included in the reference standard and index test. All data were included in a 2 × 2 table. |
| Comparative |
Not applicable |
| Notes |
No funding source mentioned. |
| Methodological quality |
| Item |
Authors' judgement |
Risk of bias |
Applicability concerns |
| DOMAIN 1: Patient selection |
| Was a consecutive or random sample of patients enrolled? |
No |
|
|
| Was a case‐control design avoided? |
No |
|
|
| Did the study avoid inappropriate exclusions? |
No |
|
|
| Could the selection of patients have introduced bias? |
|
High risk |
|
| Are there concerns that the included patients and setting do not match the review question? |
|
|
High |
| DOMAIN 2: Index test (All tests) |
| Were the index test results interpreted without knowledge of the results of the reference standard? |
Yes |
|
|
| If a threshold was used, was it pre‐specified? |
Yes |
|
|
| Was the model designed in an appropriate manner? |
Yes |
|
|
| Could the conduct or interpretation of the index test have introduced bias? |
|
Low risk |
|
| Are there concerns that the index test, its conduct, or interpretation differ from the review question? |
|
|
Low concern |
| DOMAIN 3: Reference standard |
| Is the reference standard likely to correctly classify the target condition? |
No |
|
|
| Were the reference standard results interpreted without knowledge of the results of the index tests? |
Yes |
|
|
| Could the reference standard, its conduct, or its interpretation have introduced bias? |
|
High risk |
|
| Are there concerns that the target condition as defined by the reference standard does not match the question? |
|
|
Low concern |
| DOMAIN 4: Flow and timing |
| Did all patients receive the same reference standard? |
Yes |
|
|
| Were all patients included in the analysis? |
Yes |
|
|
| Could the patient flow have introduced bias? |
|
Low risk |
|
| DOMAIN 5: Comparative |